Irish Regulator Backs Generic Substitution To Improve Access to New Medicines
This article was originally published in The Pink Sheet Daily
Executive Summary
Irish Medicines Board surveys patients' views on generic substitution and releases information leaflet.
You may also be interested in...
Ireland Cuts Drug Prices And May Also Introduce Reference Pricing
Ireland slashed the prices of 300 branded multisource medicines, including Zofran and Casodex, by around 40 percent at the start of the month, and there are strong indications that more cutbacks are to follow, with reference pricing and generic substitution as distinct possibilities
U.K. Drug Spending Plan Balances 5% Cut With Increased Access
The U.K. National Health Service could save approximately £310 million in branded drug costs in 2009 under a preliminary agreement between the government and the pharmaceutical industry
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.